Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

[1]  D. Parkin.  11. Cancers attributable to infection in the UK in 2010 , 2011, British Journal of Cancer.

[2]  Y. Qiao,et al.  Estimation of cancer cases and deaths attributable to infection in China , 2011, Cancer Causes & Control.

[3]  Hai-rim Shin,et al.  Population attributable fraction of infection-related cancers in Korea. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Franceschi,et al.  Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[5]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[6]  J. Parsonnet,et al.  Helicobacter pylori and gastric adenocarcinoma. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[8]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[9]  S. Franceschi,et al.  Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis , 2009, International journal of cancer.

[10]  R. Kurman,et al.  Systematic review of human papillomavirus prevalence in invasive penile cancer , 2009, Cancer Causes & Control.

[11]  J. Barrett,et al.  Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer , 2008, Alimentary pharmacology & therapeutics.

[12]  G. Berglund,et al.  Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma , 2007, Scandinavian journal of gastroenterology.

[13]  S. Franceschi,et al.  Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies , 2006, Cancer Epidemiology Biomarkers & Prevention.

[14]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[15]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[16]  L. Hansson,et al.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[17]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[18]  P Boffetta,et al.  A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.

[19]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.

[21]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[22]  L. Hagmar,et al.  [Cancer incidence]. , 2018, Duodecim; laaketieteellinen aikakauskirja.